Department of Neurosurgery, Juntendo University Shizuoka Hospital, Izunokuni, Shizuoka, Japan.
Department of Neurosurgery, Hakuaikai Hospital, Fuwa-gun, Gifu, Japan.
World Neurosurg. 2024 Sep;189:e370-e379. doi: 10.1016/j.wneu.2024.06.058. Epub 2024 Jun 19.
The long history of treatment for intracerebral hemorrhage (ICH) includes the development of surgical procedures. However, few studies have demonstrated that surgery improved the functional outcome. The present study used the prospective Registry of Intracerebral hemorrhage treated by endoscopic hematoma evacuation of the outcomes in endoscopic surgery, which is widely followed in Japan, to try to establish clinical evidence.
The Registry of Intracerebral hemorrhage treated by endoscopic hematoma evacuation is a multicenter, prospective registry in Japan, and included 143 surgical cases treated by certified neurosurgeons. The etiology and the location of ICH was evaluated by univariate and multivariate analyses as follows: deep, surface, intraventricular hemorrhage, cerebellum, and surgical outcome.
Hematoma location was deep in 44.8% of cases, intraventricular hemorrhage in 19.6%, surface in 21.7%, and cerebellum in 14.0%. Most cases were treated in the ultraearly stage within 8 hours. Mean hematoma evacuation rate was 83.6% and median residual hematoma volume was 3.0 ml. Duration of surgery was median 78 minutes. Rebleeding as a complication was observed in 6.7%, but only 2.9% were symptomatic. 2 cases required reoperation. Favorable outcome at 6 months was achieved in 35.8% of cases, with a mortality rate of 5.6%.
Endoscopic surgery for spontaneous ICH is safe and comparable to conventional surgery. The time required for the procedure was significantly reduced, demonstrating the minimally invasive character of the surgical burden. However, this study did not establish whether minimally invasive surgery is superior to conservative treatment. Future randomized controlled trials should clarify the effectiveness of the treatment.
脑出血(ICH)的治疗历史悠久,包括手术方法的发展。然而,很少有研究表明手术改善了功能结局。本研究使用在日本广泛应用的内镜血肿清除术治疗脑出血结果的前瞻性登记处,试图建立临床证据。
内镜血肿清除术治疗脑出血登记处是日本的一项多中心前瞻性登记处,包括 143 例由认证神经外科医生治疗的手术病例。ICH 的病因和位置通过单变量和多变量分析进行评估,如下所示:深部、表面、脑室内出血、小脑和手术结果。
血肿位置在 44.8%的病例中为深部,19.6%为脑室内,21.7%为表面,14.0%为小脑。大多数病例在 8 小时内接受超早期治疗。平均血肿清除率为 83.6%,中位数残余血肿量为 3.0ml。手术时间中位数为 78 分钟。并发症中有 6.7%发生再出血,但只有 2.9%有症状。2 例需要再次手术。6 个月时获得良好结局的比例为 35.8%,死亡率为 5.6%。
自发性脑出血的内镜手术是安全的,与传统手术相当。该手术所需时间明显缩短,显示出手术负担的微创特征。然而,本研究并未确定微创手术是否优于保守治疗。未来的随机对照试验应阐明治疗的有效性。